Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells
Xianqiang Liu,1 Meili Sun,2 Shui Yu,3 Kai Liu,4 Xirui Li,5 Huan Shi6 1Department of Breast and Thyroid Surgery, 2Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, 3Department of Radiation Oncology, 4Department of Gastrointestinal Surgery, 5Medical Department, 6Depart...
Main Authors: | Liu XQ, Sun ML, Yu S, Liu K, Li XR, Shi H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/potential-therapeutic-strategy-for-gastric-cancer-peritoneal-metastasi-peer-reviewed-article-OTT |
Similar Items
-
Issues on peritoneal metastasis of gastric cancer: an update
by: Zhen Wang, et al.
Published: (2019-12-01) -
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
by: Alexandra Frazao, et al.
Published: (2019-03-01) -
Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
by: Tobias Zöller, et al.
Published: (2018-03-01) -
MiR-136 inhibits gastric cancer–specific peritoneal metastasis by targeting HOXC10
by: Jianyong Zheng, et al.
Published: (2017-06-01) -
Emerging Concepts on the NKG2D Receptor- NKG2D Ligand Axis in Health and Diseases
Published: (2020)